AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
CHICAGO -- The epidemic of type 2 diabetes has grown to the point that it may be worthwhile to perform an oral glucose tolerance test on everyone at increased risk for cardiovascular disease, Dr. Robert Calif. asserted at the annual meeting of the American College of Cardiology.
Using such a strategy, physicians could identify and treat a substantial number of individuals with unsuspected diabetes- and counsel an even larger number of patients with impaired glucose tolerance, said Dr. Califf, professor of medicine at Duke University, Durham, N.C., and director of the Duke Clinical Research Institute.
He reported on 17,532 individuals who underwent an oral glucose tolerance test as part of the screening process for participation in the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial.
To be eligible for screening, candidates had to be ...
Source: HighBeam Research, CV risk may warrant oral glucose tolerance test. (Type Diabetes).